In this Issue:
Eltrombopag in HCV + thrombocytopenia
Simeprevir in treatment-experienced HCV
An all-oral, IFN-free + RBVfree regimen in HCV G1 infection
Host + viral factors in spontaneous HCV clearance
Autocrine loop in genesis of HCV liver fibrosis?
rs738409 genotype affects post-transplant outcome
TDF provides effective longterm HBV suppression
HCV p7: a new target for antivirals?
BMP4 promotes HCV replication
Nitazoxanide/PegIFN/RBV in HCV G4 infection
Please login below to download this issue (PDF)